Novo's dark forecasts have been disproved: "We're stronger in the US than we've been in many years"

Danish pharmaceutical company Novo Nordisk's largest single market business has proven – in record time – to be stronger than the firm expected.
Novo Nordisk CEO Lars Fruergaard Jørgensen. | Photo: Stine Bidstrup/ERH
Novo Nordisk CEO Lars Fruergaard Jørgensen. | Photo: Stine Bidstrup/ERH
BY BENJAMIN WERNER CHRISTENSEN, TRANSLATED BY NIELSINE NIELSEN

Novo Nordisk has refuted skepticism and successfully led its US business to provide even better results than the pharmaceutical company had otherwise dared hope.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading